“After the University of Texas learned of the articles, the plaintiff did not receive the promised contract for signing. He was told that the recruitment process has ended. […] No academic institution is currently interested to recruit the plaintiff
despite his enormous scientific reputation.” – Lucas Brost, van Deursen’s lawyer.
Jan van Deursen had to resign from Mayo Clinic over bullying charges. With his company Unity Biotech’s phase 2 clinical trial failed, stock devalued and staff laid-off, van Deursen sued me in German court about the reproducibility of his senolytics research.
The 2015 Nature Cell Biology paper by the Spanish cancer researcher Carlos Lopez-Otin and his US partner George Q Daley, stem cell titan and dean of Harvard Medical School, is being retracted. First author and Lopez-Otin’s student Clara Soria-Valles caused Daley even more trouble: her next groundbreaking paper was meant to be already published, but it is not even submitted and might never be.
Following my reporting, the cancer researcher Carlos López-Otín abandoned his ERC-funded 36-member-strong “Degradome” lab at the University of Oviedo in Spain and moved in with his collaborator in Paris, France, Guido Kroemer. Yet Lopez-Otin’s data integrity issues seem as poppycock compared to what Kroemer and his life partner Laurence Zitvogel dished out to the scientific community.
Janine Erler is a star of Danish cancer research, funded by ERC. Her earlier research led to the discovery of the key role of the enzyme lysyl oxidase in cancer metastasis and brought the scientist and businesswoman very close to curing cancer. Until some sad envious bad-wishers found duplicated gel bands in Erler papers.